Skip to main content
Year archive

AMPLIA THERAPEUTICS LIMITED — 2020 filings

All 69 regulatory filings released by AMPLIA THERAPEUTICS LIMITED (ATX) in 2020, sourced directly from the official regulator.

69 Filings
2020 Period
2020 filings (69)
Filing Released Lang
Shareholder Update - 2020 Review 17 pages 1.1MB
Annual Report
2020-12-16 English
Amplia Receives $0.53m R&D Tax Incentive 1 page 108
Capital/Financing Update
2020-12-01 English
Appendix 4D and Financial Report Half Year Ended 30 Sep 2020 14 pages 773.5KB
Interim / Quarterly Report
2020-11-26 English
Appendix 2A - Allot Shares upon Exercise of Options 16 pages 272.3KB
Capital/Financing Update
2020-11-23 English
Notice ASX LR 3.11.2 - Change of Exercise Price of Options 1
Capital/Financing Update
2020-11-01 English
ATX - Sep 2020 Quarter Activities and Cashflow Reports 7 pages 172.2KB
Interim / Quarterly Report
2020-10-28 English
Amplia Presentation to Reach Market Services - Meet the CEO 18 pages 3.3MB
Investor Presentation
2020-10-20 English
Response to ASX Price Query 4 pages 212.0KB
Regulatory Filings
2020-10-19 English
First Human Dose in Phase 1 Clinical Trial of AMP945 1
Regulatory Filings
2020-10-07 English
CEO Presentation to AGM 14 pages 1.7MB
AGM Information
2020-09-17 English
Results of Annual General Meeting 2 pages 121.1KB
Declaration of Voting Results & Voting Rights Announcements
2020-09-17 English
Appendix 2A - Application for Quotation of Shares 16 pages 267.0KB
Capital/Financing Update
2020-09-17 English
Section 708A Cleansing Notice - Allotment of Shares 1
Capital/Financing Update
2020-09-17 English
Change of Director's Interest Notice - Dr. C. Burns 3 pages 175.7KB
Director's Dealing
2020-09-17 English
Change of Director's Interest Notice - Dr. Robert Peach 4 pages 176.8KB
Director's Dealing
2020-09-17 English
Change of Director's Interest Notice - Dr. Warwick Tong 4 pages 180.7KB
Director's Dealing
2020-09-17 English
Amplia Receives Ethics Clearance fo Conduct Phase 1 Trial 2 pages 113.1KB
Regulatory Filings
2020-09-07 English
Appendix 3G - Notification of Issue of Securities - Options 15 pages 244.7KB
Share Issue/Capital Change
2020-09-01 English
Amplia Appoints Dr Mark Devlin as Chief Scientific Officer 1
Board/Management Information
2020-08-30 English
Notice of Annual General Meeting & Proxy - YE 31 March 2020 22 pages 749.2KB
Regulatory Filings
2020-08-16 English
Change in substantial holding 3 pages 142.2KB
Regulatory Filings
2020-08-05 English
Change in substantial holding 3 pages 228.9KB
Regulatory Filings
2020-08-05 English
Change of Directors Interest - Dr W Tong - Entitlement Offer 4 pages 180.2KB
Director's Dealing
2020-08-04 English
Change of Director Interest - Dr Lambert - Entitlement Offer 4 pages 180.8KB
Director's Dealing
2020-08-04 English
Appendix 2A - Retail Entitlement Offer 16 pages 266.5KB
Capital/Financing Update
2020-08-03 English
Annual Report to Shareholders - YE 31 March 2020 52 pages 1.1MB
Regulatory Filings
2020-07-30 English
2020 Corporate Governance Statement 14 pages 216.5KB
Governance Information
2020-07-30 English
Appendix 4G - Key to Corporate Governance Disclosures 12 pages 228.6KB
Governance Information
2020-07-30 English
Entitlement Offer Completed 1 page 111.7KB
Capital/Financing Update
2020-07-29 English
Quarterly Activities and Cashflow Reports - June 2020 7 pages 176.4KB
Interim / Quarterly Report
2020-07-26 English
Nucleus Network Appointed to Conduct Phase 1 Clinical Trial 1
Capital/Financing Update
2020-07-22 English
AGM to be held Friday 18 September 2020 1 page 106.
AGM Information
2020-07-19 English
Change in substantial holding 3 pages 145.1KB
Regulatory Filings
2020-07-13 English
Becoming a substantial holder 4 pages 273.5KB
Regulatory Filings
2020-07-13 English
Becoming a substantial holder 4 pages 285.9KB
Regulatory Filings
2020-07-13 English
Change of Director's Interest Notice - Dr. Warwick Tong 4 pages 180.3KB
Director's Dealing
2020-07-13 English
Appendix 2A - Institutional Entitlement Offer 15 pages 174.8KB
Capital/Financing Update
2020-07-09 English
Entitlement Offer - Despatch of Retail Offer Booklet 58 pages 2.3MB
Capital/Financing Update
2020-07-07 English
Institutional Entitlement Offer Completed 2 pages 115.3KB
Capital/Financing Update
2020-07-02 English
Pause in Trading 1 page 110.7KB
Regulatory Filings
2020-06-30 English
Trading Halt 2 pages 494.7KB
Capital/Financing Update
2020-06-30 English
Entitlement Offer to Fund Phase 1 Clinical Trial 5 pages 233.1KB
Capital/Financing Update
2020-06-30 English
Capital Raising - Investor Presentation 35 pages 3.8MB
Investor Presentation
2020-06-30 English
Entitlement Offer Cleansing Notice 2 pages 88.2KB
Capital/Financing Update
2020-06-30 English
Appendix 3B - Rights Issue 50 pages 558.1KB
Capital/Financing Update
2020-06-30 English
Preliminary Toxicology Studies Support Phase1 Clinical Trial 1
Regulatory Filings
2020-06-29 English
Trading Halt 2 pages 139.1KB
Regulatory Filings
2020-06-28 English
Full Year Statutory Accounts - YE 31 March 2020 48 pages 1.2MB
Annual Report
2020-06-24 English
Investor Presentation 32 pages 5.1MB
Investor Presentation
2020-06-01 English
Preliminary Final Report - YE 31 March 2020 10 pages 231.8KB
Annual Report
2020-05-28 English
FDA Orphan Drug Designation - Idiopathic Pulmonary Fibrosis 2 pages 118.6KB
Regulatory Filings
2020-05-18 English
App 4C - Quarterly Cash Flow Report - March 2020 Qtr 6 pages 161.0KB
Interim / Quarterly Report
2020-04-27 English
Quarterly Activities Report - March 2020 Qtr 3 pages 121.9KB
Interim / Quarterly Report
2020-04-27 English
Shares to be Released from Voluntary Escrow 1 page
Capital/Financing Update
2020-04-06 English
FDA Awards Orphan Drug Designation for Pancreatic Cancer 1
Regulatory Filings
2020-03-24 English
Professor Paul Timpson Joins Amplia's SAB 1 page 11
Board/Management Information
2020-02-12 English
Initial Director's Interest Notice - John Lambert 3 pages 169.6KB
Director's Dealing
2020-02-11 English
Final Director's Interest Notice - Cooke 3 pages 163.4KB
Director's Dealing
2020-02-06 English
Final Director's Interest Notice - Wilkinson 3 pages 163.6KB
Director's Dealing
2020-02-06 English
Final Director's Interest Notice - Behrenbruch 3 pages 164.4KB
Director's Dealing
2020-02-06 English
Board Restructuring 1 page 111.7KB
Board/Management Information
2020-02-05 English
Dr. John Lambert appointed as Managing Director 1 p
Board/Management Information
2020-02-05 English
Appendix 4C Cash Flow - Dec 2019 Qtr 7 pages 185.9KB
Interim / Quarterly Report
2020-01-29 English
Placement Cleasing Statement 1 page 110.9KB
Capital/Financing Update
2020-01-29 English
Becoming a substantial holder 3 pages 201.8KB
Regulatory Filings
2020-01-27 English
Ceasing to be a substantial holder - Behrenbruch 2 pages 92.0KB
Major Shareholding Notification
2020-01-27 English
Appendix 3B - Placement 12 pages 241.0KB
Capital/Financing Update
2020-01-23 English
Amplia Therapeutics Undertakes Placement 1 page 107
Capital/Financing Update
2020-01-19 English
Trading Halt 2 pages 186.6KB
Capital/Financing Update
2020-01-15 English